Primetrace Records INR 550 Cr ARR with 50x growth in three years, delivering a rare profitability story in India's consumer ...
The rupee’s appreciation phases have become shorter and less intense amid tighter management and lower volatility ...
Primetrace, an AI-first consumer startup, achieved INR 550 Cr ARR with 50x growth in three years by focusing on real user ...
South Africa is on track to fall short of the 1.5% of gross domestic product expenditure on research and development by 2030, ...
Everybody acts differently while they are being watched, especially by those with authority. Whether it's your boss sitting ...
New analysis of 6,900+ real claims show average R&D tax credit values have grown 245% since 2018 R&D Tax Credit Claims by ...
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that the 45th subject has been enrolled in its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin in ...
Despite efforts to draw attention to the issue by former president of the European Central Bank Mario Draghi with his EU competitiveness report, the latest figures of the world’s top 2,000 R&D ...
The Pioneer on MSN
While India builds data centres, China is building data markets
India, March 16 -- While Washington debates how artificial intelligence may influence the next phase of warfare, and New ...
Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoingPhase 1: 83% ORR at RP2D and 100% ORR in the target Phase ...
Welcome to the conference call hosted by Dare Bioscience to review the company's 2025 financial results and to review -- provide a business update. This call is being recorded. My name is Desiree, and ...
Dose escalation for NKX019 advanced to 4 billion cells per dose on days 0, 3 and 7 for a total of 12 billion cells per cycleInitial clinical data from Ntrust-1 and Ntrust-2 targeted for presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results